Emergent BioSolutions to Participate in Investor Conferences

Rhea-AI Summary

Emergent BioSolutions (NYSE: EBS) will participate in several upcoming investor conferences, showcasing its commitment to growth and communication with stakeholders. Key dates include:

• Jefferies Inaugural Global Plasma Summit on March 11, 2021, at 12:50 PM EST.
• KeyBanc Life Sciences & MedTech Investor Forum on March 24, 2021, at 1:15 PM EST.
• Chardan 4th Annual Manufacturing Summit on April 26-27, 2021, with updated details on the Emergent website.
• Truist 7th Annual Life Sciences Summit on May 4-5, 2021, with presentation details to be announced.

These events will likely discuss recent developments and financial guidance.

GAITHERSBURG, Md., March 01, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences:

• Jefferies Inaugural Global Plasma Summit
  March 11, 2021
  Company fireside chat scheduled at 12:50 pm EST
  
  
• KeyBanc Life Sciences & MedTech Investor Forum
  March 24, 2021
  Company fireside chat scheduled at 1:15 pm EST

• Chardan 4^th Annual Manufacturing Summit
  April 26-27, 2021
  Fireside chat date and time will be updated on the Emergent website as the information becomes available.

• Truist 7^th Annual Life Sciences Summit
  May 4-5, 2021
  Presentation date and time will be updated on the Emergent website as the information becomes available.
  

For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.

About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our website and follow us on LinkedIn, Twitter, and Instagram.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
burrowsr@ebsi.com

Media Contact:
Nina DeLorenzo
SVP, Global Communications & Public Affairs
mediarelations@ebsi.com

FAQ

When is Emergent BioSolutions participating in the Jefferies Inaugural Global Plasma Summit?

Emergent BioSolutions will participate in the Jefferies Inaugural Global Plasma Summit on March 11, 2021, at 12:50 PM EST.

What is the date for the KeyBanc Life Sciences & MedTech Investor Forum?

The KeyBanc Life Sciences & MedTech Investor Forum is scheduled for March 24, 2021, at 1:15 PM EST.

When will the Chardan 4th Annual Manufacturing Summit take place?

The Chardan 4th Annual Manufacturing Summit will take place on April 26-27, 2021.

What can investors expect from the Truist 7th Annual Life Sciences Summit?

The Truist 7th Annual Life Sciences Summit is set for May 4-5, 2021, with presentation details to be announced.

Will Emergent BioSolutions provide updates on their financial results during these conferences?

Yes, Emergent BioSolutions' presentations may include discussions on recent business developments, financial results, and guidance.